NLRP3 Inflammasome Activation Induced by Engineered Nanomaterials

被引:145
|
作者
Sun, Bingbing [1 ,2 ]
Wang, Xiang [1 ,2 ]
Ji, Zhaoxia [1 ,2 ]
Li, Ruibin [1 ,2 ]
Xia, Tian [1 ,2 ]
机构
[1] Univ Calif Los Angeles, Dept Med, Div NanoMed, Los Angeles, CA 90095 USA
[2] Univ Calif Los Angeles, Calif NanoSyst Inst, Los Angeles, CA 90095 USA
基金
美国国家科学基金会;
关键词
engineered nanomaterials; inflammasomes; inflammation; nanotoxicology; NLRP3; MULTIWALLED CARBON NANOTUBES; INNATE IMMUNE-RESPONSE; NALP3; INFLAMMASOME; OXIDATIVE STRESS; DENDRITIC CELLS; CYTOCHROME-C; NANOPARTICLES ACTIVATE; CASPASE-1; ACTIVATION; IL-1-BETA PRODUCTION; AIM2;
D O I
10.1002/smll.201201962
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Engineered nanomaterials (ENMs) continue to attract significant attention because they have novel physicochemical properties that can improve the functions of products that will benefit human lives. However, the physicochemical properties that make ENMs attractive could interact with biological systems and induce cascades of events that cause toxicological effects. Recently, there have been more studies suggesting inflammasome activation may play an important role in ENM-induced biological responses. Inflammasomes are a family of multiprotein complexes that are increasingly recognized as major mediators of the host immune system. Among these, NLRP3 inflammasome is the most studied that could directly interact with ENMs to generate inflammatory responses. In this review, the ENM physicochemical properties are linked to NLRP3 inflammasome activation. An understanding of the mechanisms of ENMNLRP3 inflammasome interactions will provide us with strategies for safer nanomaterial design and therapy.
引用
收藏
页码:1595 / 1607
页数:13
相关论文
共 50 条
  • [41] Atranorin inhibits NLRP3 inflammasome activation by targeting ASC and protects NLRP3 inflammasome-driven diseases
    Hao-yu Wang
    Xi Lin
    Guan-gen Huang
    Rong Zhou
    Shu-yue Lei
    Jing Ren
    Kai-rong Zhang
    Chun-lan Feng
    Yan-wei Wu
    Wei Tang
    Acta Pharmacologica Sinica, 2023, 44 : 1687 - 1700
  • [42] RACK1 Mediates NLRP3 Inflammasome Activation by Promoting NLRP3 Active Conformation and Inflammasome Assembly
    Duan, Yanhui
    Zhang, Lingzhi
    Angosto-Bazarra, Diego
    Pelegrin, Pablo
    Nunez, Gabriel
    He, Yuan
    CELL REPORTS, 2020, 33 (07):
  • [43] Mitochondrial Cardiolipin Is Required for Nlrp3 Inflammasome Activation
    Iyer, Shankar S.
    He, Qiong
    Janczy, John R.
    Elliott, Eric I.
    Zhong, Zhenyu
    Olivier, Alicia K.
    Sadler, Jeffrey J.
    Knepper-Adrian, Vickie
    Han, Renzhi
    Qiao, Liang
    Eisenbarth, Stephanie C.
    Nauseef, William M.
    Cassel, Suzanne L.
    Sutterwala, Fayyaz S.
    IMMUNITY, 2013, 39 (02) : 311 - 323
  • [44] Initiation and perpetuation of NLRP3 inflammasome activation and assembly
    Elliott, Eric I.
    Sutterwala, Fayyaz S.
    IMMUNOLOGICAL REVIEWS, 2015, 265 (01) : 35 - 52
  • [45] Targeting NLRP3 Inflammasome Activation in Severe Asthma
    Theofani, Efthymia
    Semitekolou, Maria
    Morianos, Ioannis
    Samitas, Konstantinos
    Xanthou, Georgina
    JOURNAL OF CLINICAL MEDICINE, 2019, 8 (10)
  • [46] Acetylation is required for full activation of the NLRP3 inflammasome
    Zhang, Yening
    Luo, Ling
    Xu, Xueming
    Wu, Jianfeng
    Wang, Fupeng
    Lu, Yanyan
    Zhang, Ningjie
    Ding, Yingying
    Lu, Ben
    Zhao, Kai
    NATURE COMMUNICATIONS, 2023, 14 (01)
  • [47] NLRP3 inflammasome activation in Alzheimer's disease
    Tzeng, Te-Chen
    Golenbock, Douglas
    JOURNAL OF IMMUNOLOGY, 2014, 192
  • [48] Celastrol specifically inhibits the activation of NLRP3 inflammasome
    Xuesong Sang
    Yihui Chen
    Wei Chen
    Jing Xie
    Guangxun Meng
    Jin Zhong
    Taisheng Li
    Ailing Lu
    Science China Life Sciences, 2018, (03) : 355 - 357
  • [49] Activation of NLRP3 inflammasome in A1 astrocytes
    Valente, C. A.
    Ribeiro, A. F.
    Almeida, C. C.
    Sebastiao, A. M.
    GLIA, 2019, 67 : E621 - E621
  • [50] Microglial NLRP3 inflammasome activation in multiple sclerosis
    Olcum, Melis
    Tastan, Bora
    Kiser, Cagla
    Genc, Sermin
    Genc, Kursad
    INFLAMMATORY DISORDERS, PT A, 2020, 119 : 247 - 308